ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions

December 16, 1983

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Dugan Head ACCC, Yarbro President Elects; Amos Honored

March 18, 1983

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Recision, 1981 Budget Threats Hangover NCI

March 14, 1980